Cargando…
A Novel Non-Peptidic Agonist of the Ghrelin Receptor with Orexigenic Activity In vivo
Loss of appetite in the medically ill and ageing populations is a major health problem and a significant symptom in cachexia syndromes, which is the loss of muscle and fat mass. Ghrelin is a gut-derived hormone which can stimulate appetite. Herein we describe a novel, simple, non-peptidic, 2-pyridon...
Autores principales: | Pastor-Cavada, Elena, Pardo, Leticia M., Kandil, Dalia, Torres-Fuentes, Cristina, Clarke, Sarah L., Shaban, Hamdy, McGlacken, Gerard P., Schellekens, Harriet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098229/ https://www.ncbi.nlm.nih.gov/pubmed/27819353 http://dx.doi.org/10.1038/srep36456 |
Ejemplares similares
-
Quinolones Modulate Ghrelin Receptor Signaling: Potential for a Novel Small Molecule Scaffold in the Treatment of Cachexia
por: Torres-Fuentes, Cristina, et al.
Publicado: (2018) -
Relationship between Orexigenic Peptide Ghrelin Signal, Gender Difference and Disease
por: Yamada, Chihiro
Publicado: (2021) -
Disrupting the ghrelin-growth hormone axis limits ghrelin's orexigenic but not glucoregulatory actions
por: Gupta, Deepali, et al.
Publicado: (2021) -
Hypothalamic mTOR Signaling Mediates the Orexigenic Action of Ghrelin
por: Martins, Luís, et al.
Publicado: (2012) -
Anti-ghrelin immunoglobulins modulate ghrelin stability and its orexigenic effect in obese mice and humans
por: Takagi, Kuniko, et al.
Publicado: (2013)